On the operating front, earnings before interest, tax, depreciation and amortisation (EBITDA) is expected to rise around 60 percent and margin may expand by more than 650 basis points YoY.from Moneycontrol Results News https://ift.tt/2XwI2sO
Tuesday 26 May 2020
Sun Pharma Q4 profit, revenue expected to report healthy growth on low base
On the operating front, earnings before interest, tax, depreciation and amortisation (EBITDA) is expected to rise around 60 percent and margin may expand by more than 650 basis points YoY.from Moneycontrol Results News https://ift.tt/2XwI2sO